BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30737205)

  • 21. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
    Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
    Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wedge-shaped microfluidic chip for circulating tumor cells isolation and its clinical significance in gastric cancer.
    Yang C; Zhang N; Wang S; Shi D; Zhang C; Liu K; Xiong B
    J Transl Med; 2018 May; 16(1):139. PubMed ID: 29792200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer.
    Vetter M; Landin J; Szczerba BM; Castro-Giner F; Gkountela S; Donato C; Krol I; Scherrer R; Balmelli C; Malinovska A; Zippelius A; Kurzeder C; Heinzelmann-Schwarz V; Weber WP; Rochlitz C; Aceto N
    Breast Cancer Res; 2018 Nov; 20(1):141. PubMed ID: 30458879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow-based immunomagnetic enrichment of circulating tumor cells from diagnostic leukapheresis product.
    Stevens M; Mentink A; Coumans FAW; Dathathri E; Isebia KT; Kraan J; de Wit R; Martens JWM; Terstappen LWMM
    Mol Oncol; 2023 Dec; ():. PubMed ID: 38073130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
    Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
    Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
    Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
    J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma.
    Vismara M; Reduzzi C; Silvestri M; Murianni F; Lo Russo G; Fortunato O; Motta R; Lanzoni D; Giovinazzo F; Miodini P; Pasquali S; Suatoni P; Pastorino U; Roz L; Sozzi G; Cappelletti V; Bertolini G
    Clin Chem; 2022 May; 68(5):691-701. PubMed ID: 35304611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.
    Iwata H; Masuda N; Yamamoto D; Sagara Y; Sato N; Yamamoto Y; Saito M; Fujita T; Oura S; Watanabe J; Tsukabe M; Horiguchi K; Hattori S; Matsuura Y; Kuroi K
    Breast Cancer Res Treat; 2017 Apr; 162(3):501-510. PubMed ID: 28181129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer.
    Neves RP; Raba K; Schmidt O; Honisch E; Meier-Stiegen F; Behrens B; Möhlendick B; Fehm T; Neubauer H; Klein CA; Polzer B; Sproll C; Fischer JC; Niederacher D; Stoecklein NH
    Clin Chem; 2014 Oct; 60(10):1290-7. PubMed ID: 25267515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An ultra-high-throughput spiral microfluidic biochip for the enrichment of circulating tumor cells.
    Warkiani ME; Khoo BL; Tan DS; Bhagat AA; Lim WT; Yap YS; Lee SC; Soo RA; Han J; Lim CT
    Analyst; 2014 Jul; 139(13):3245-55. PubMed ID: 24840240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system.
    Andreopoulou E; Yang LY; Rangel KM; Reuben JM; Hsu L; Krishnamurthy S; Valero V; Fritsche HA; Cristofanilli M
    Int J Cancer; 2012 Apr; 130(7):1590-7. PubMed ID: 21469140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
    Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M
    Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementing microwell slides for detection and isolation of single circulating tumor cells from complex cell suspensions.
    Yang L; Rivandi M; Franken A; Hieltjes M; van der Zaag PJ; Nelep C; Eberhardt J; Peter S; Niederacher D; Fehm T; Neubauer H
    Cytometry A; 2022 Dec; 101(12):1057-1067. PubMed ID: 35698878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients.
    Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B
    Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of circulating tumor cells in metastatic breast cancer patients.
    Sanislo L; Vertakova-Krakovska B; Kuliffay P; Brtko J; Galbava A; Galbavy S
    Endocr Regul; 2011 Jul; 45(3):113-24. PubMed ID: 21793623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung Cancer.
    Obermayr E; Agreiter C; Schuster E; Fabikan H; Weinlinger C; Baluchova K; Hamilton G; Hochmair M; Zeillinger R
    Cells; 2019 Aug; 8(8):. PubMed ID: 31412616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Studies on Viable Circulating Tumor Cells.
    Pantel K; Alix-Panabières C
    Clin Chem; 2016 Feb; 62(2):328-34. PubMed ID: 26637479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cancer: a pilot study.
    Stojadinovic A; Mittendorf EA; Holmes JP; Amin A; Hueman MT; Ponniah S; Peoples GE
    Ann Surg Oncol; 2007 Dec; 14(12):3359-68. PubMed ID: 17906897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer.
    Brungs D; Lynch D; Luk AW; Minaei E; Ranson M; Aghmesheh M; Vine KL; Carolan M; Jaber M; de Souza P; Becker TM
    World J Gastroenterol; 2018 Feb; 24(7):810-818. PubMed ID: 29467551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.